Omniab Inc Stock Net Asset
| OABI Stock | USD 1.85 0.01 0.54% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess OmniAb's long-term financial health and intrinsic value.
OmniAb | Net Asset | Build AI portfolio with OmniAb Stock |
OmniAb Inc Company Net Asset Analysis
OmniAb's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current OmniAb Net Asset | 325.56 M |
Most of OmniAb's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OmniAb Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
OmniAb Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for OmniAb is extremely important. It helps to project a fair market value of OmniAb Stock properly, considering its historical fundamentals such as Net Asset. Since OmniAb's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of OmniAb's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of OmniAb's interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
OmniAb Total Assets
Total Assets |
|
Based on the recorded statements, OmniAb Inc has a Net Asset of 325.56 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
OmniAb Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OmniAb's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OmniAb could also be used in its relative valuation, which is a method of valuing OmniAb by comparing valuation metrics of similar companies.OmniAb is currently under evaluation in net asset category among its peers.
OmniAb Institutional Holders
Institutional Holdings refers to the ownership stake in OmniAb that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of OmniAb's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing OmniAb's value.| Shares | Royce & Associates, Lp | 2025-06-30 | 867.1 K | Northern Trust Corp | 2025-06-30 | 836.9 K | Charles Schwab Investment Management Inc | 2025-06-30 | 832.3 K | Towerview Llc | 2025-06-30 | 831.1 K | Jpmorgan Chase & Co | 2025-06-30 | 793.7 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 767.6 K | Renaissance Technologies Corp | 2025-06-30 | 707.5 K | Millennium Management Llc | 2025-06-30 | 650.3 K | Woodstock Corp | 2025-06-30 | 621.7 K | Whitefort Capital Management, Lp. | 2025-06-30 | 10.2 M | Blackrock Inc | 2025-06-30 | 7 M |
OmniAb Fundamentals
| Return On Equity | -0.22 | ||||
| Return On Asset | -0.13 | ||||
| Operating Margin | (8.10) % | ||||
| Current Valuation | 227.89 M | ||||
| Shares Outstanding | 143.96 M | ||||
| Shares Owned By Insiders | 12.75 % | ||||
| Shares Owned By Institutions | 55.86 % | ||||
| Number Of Shares Shorted | 5.27 M | ||||
| Price To Book | 0.96 X | ||||
| Price To Sales | 12.63 X | ||||
| Revenue | 26.39 M | ||||
| Gross Profit | 20.8 M | ||||
| EBITDA | (50.92 M) | ||||
| Net Income | (62.03 M) | ||||
| Total Debt | 23.16 M | ||||
| Debt To Equity | 0.11 % | ||||
| Current Ratio | 0.57 X | ||||
| Book Value Per Share | 1.93 X | ||||
| Cash Flow From Operations | (39.66 M) | ||||
| Short Ratio | 9.08 X | ||||
| Earnings Per Share | (0.59) X | ||||
| Target Price | 7.33 | ||||
| Number Of Employees | 114 | ||||
| Beta | 0.87 | ||||
| Market Capitalization | 266.32 M | ||||
| Total Asset | 325.56 M | ||||
| Retained Earnings | (101.4 M) | ||||
| Working Capital | 53.05 M | ||||
| Net Asset | 325.56 M |
About OmniAb Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OmniAb Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OmniAb using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OmniAb Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether OmniAb Inc is a strong investment it is important to analyze OmniAb's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact OmniAb's future performance. For an informed investment choice regarding OmniAb Stock, refer to the following important reports:Check out OmniAb Piotroski F Score and OmniAb Altman Z Score analysis. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OmniAb. If investors know OmniAb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OmniAb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Revenue Per Share | Quarterly Revenue Growth (0.46) | Return On Assets | Return On Equity |
The market value of OmniAb Inc is measured differently than its book value, which is the value of OmniAb that is recorded on the company's balance sheet. Investors also form their own opinion of OmniAb's value that differs from its market value or its book value, called intrinsic value, which is OmniAb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OmniAb's market value can be influenced by many factors that don't directly affect OmniAb's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OmniAb's value and its price as these two are different measures arrived at by different means. Investors typically determine if OmniAb is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OmniAb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.